Name: EXACT SCIENCES CORP (EXAS) Stock
Brand: EXACT SCIENCES CORP
Rating: 7 (3 reviews)

EXAS Latest News, Press Relases and Analysis

All

Press Releases

13 hours ago - By: The Motley Fool - Mentions: ROKU

2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

a day ago - By: Zacks Investment Research - Mentions: BSX AMN WST

AMN Stock Gains Following Q3 Earnings & Revenue Beat, Margins Down

a day ago - By: Zacks Investment Research - Mentions: BSX WST DOCS

Doximity Stock Down Despite Q2 Earnings Beat, Revenues Up Y/Y

2 days ago - By: Exact Sciences Corp.

Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test

2 days ago - By: Zacks Investment Research - Mentions: BSX QDEL WST

QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand

5 days ago - By: Benzinga

These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results

9 days ago - By: Benzinga

Earnings Preview: Exact Sciences

2 days ago - By: Zacks Investment Research - Mentions: BSX WST INGN

Inogen Stock Dips Despite Q3 Earnings Beat, Revenues Up Y/Y

2 days ago - By: Zacks Investment Research - Mentions: BSX WST PACB

PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y

2 days ago - By: Zacks Investment Research - Mentions: BSX CNMD WST

CONMED Q3 Earnings and Revenues Beat Estimates, Margins Contract

2 days ago - By: Zacks Investment Research - Mentions: BSX BDX WST

BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up

3 days ago - By: Zacks Investment Research

Earnings Estimates Rising for Exact Sciences (EXAS): Will It Gain?

3 days ago - By: Zacks Investment Research - Mentions: BSX WST HIMS

Hims & Hers Stock Slips Post Y/Y Q3 Earnings Decline, Margins Contract

3 days ago - By: Zacks Investment Research - Mentions: BSX MASI WST

MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand

4 days ago - By: Zacks Investment Research - Mentions: ALKS FOLD CRMD

Amicus' Q3 Earnings Beat, Higher Product Sales Drive Y/Y Revenues

4 days ago - By: Zacks Investment Research

Here's Why Exact Sciences (EXAS) is a Strong Growth Stock

4 days ago - By: The Motley Fool - Mentions: MMM

Why Exact Sciences Stock Blasted Higher on Tuesday

4 days ago - By: Zacks Investment Research

Exact Sciences (EXAS) is an Intriguing Medical Stock to Watch After Q3 Earnings

5 days ago - By: Exact Sciences Corp.

Exact Sciences to Participate in November Investor Conference

5 days ago - By: Zacks Investment Research - Mentions: ARMP

Exact Sciences (EXAS) Q3 Earnings and Revenues Beat Estimates

5 days ago - By: Investor's Business Daily

Exact Sciences Flirts With A Breakout On Guidance Hike, Sales Beat

5 days ago - By: Exact Sciences Corp.

Exact Sciences Announces Third Quarter 2025 Results

8 days ago - By: Zacks Investment Research - Mentions: VRTX RIGL ANIP

Rigel Gears Up to Report Q3 Earnings: Here's What to Expect

8 days ago - By: Zacks Investment Research - Mentions: KGC DAVE CPNG

Coupang Set to Report Q3 Earnings: What's in Store for the Stock?

9 days ago - By: Zacks Investment Research - Mentions: ARQT

Arcutis Biotherapeutics, Inc. (ARQT) Hits Fresh High: Is There Still Room to Run?

10 days ago - By: Zacks Investment Research - Mentions: ALNY VRTX ZTS

Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect

13 days ago - By: Exact Sciences Corp.

Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps

16 days ago - By: Zacks Investment Research - Mentions: MOH EVR ANIP

EXACT SCIENCES CORP (EXAS) Stock News